Discover 1,416 paid clinical trials in Sarasota, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,416
Active & Responsive
A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
for
Parkinson Disease
Location: Tampa FL, Orlando FL, Boca Raton FL, Hallandale FL,
Sponsor: Appello Pharmaceuticals, Inc.
Sex: All
Age: 30 - 70+
Code: NCT07432958
Phase 2, Recruiting
Active & Responsive
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
for
Irritable Bowel Syndrome
Location: Tampa FL, Port Orange FL, Boca Raton FL, Miami FL,
Sponsor: Dynogen Pharmaceuticals
Sex: Female
Age: 18 - 65
Code: NCT00547469
Phase 2, Phase 3, Recruiting
Active & Responsive
A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
for
Migraine
Location: Tampa FL, Lakeland FL, Orlando FL, Ocoee FL,
Sponsor: TriGemX Bio, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07816367
Phase 3, Recruiting
Active & Responsive
Twiist Postmarket Surveillance Study for Type 1 Diabetes
for
Type 1 Diabetes (T1D), Type 1 Diabetes Mellitus
Location: Tampa FL
Sponsor: Deka Research and Development
Sex: All
Age: 6+
Code: NCT07356089
Recruiting
Active & Responsive
Efficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes Mellitus
Get alerts for new trials in your area by subscribing now
Active & ResponsiveNew
A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
for
Type 2 Diabetes Mellitus
Location: Lakeland FL, Lake City FL, Ridgeland MS, Kingsport TN,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07662109
Phase 3, Recruiting
Active & Responsive
A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin and Placebo on LDL-C in LLT-naïve Patients.